Early Health Focus Define Ventures is a leading early-stage health tech fund with a large AUM of $800 million and a portfolio emphasis across incubation, seed, Series A, and Series B, signaling strong potential for co-investment opportunities and syndicated deals with other health-focused firms.

Strong Exits, Credibility The team’s track record of $22 billion in exit value from category-defining digital health companies (e.g., Livongo, Evolent, Hims & Hers) enhances credibility for syndication, easier deal flow, and greater leverage when engaging potential portfolio additions or co-investors.

Active Platform Growth Frequent recent investments across AI, automation, virtual care, and health AI agents indicate a readiness to back scalable health tech across stages, suggesting opportunities to position value propositions around category-defining solutions and rapid go-to-market support.

Leadership & Network New venture partners with industry pedigree such as Carolyn Magill and Bruce Broussard expand strategic access to clinical data, payer networks, and incumbents, providing doors to strategic partnerships, pilot programs, and potential strategic investments.

Global Collaboration The fund’s co-investors and notable backers from YC, Yale New Haven Ventures, and Peak XV Partners, coupled with a robust tech stack and health-centric thesis, present cross-portfolio collaboration angles for co-led rounds, accelerators, and shared diligence to de-risk investments.